Topoisomerase I Gene Copy Number and Drug Sensitivity
Author Information
Author(s): HL McLeod, WN Keith
Primary Institution: University of Glasgow
Hypothesis
Altered topoisomerase I gene copy number affects intrinsic drug sensitivity in cancer cell lines.
Conclusion
The study demonstrates a significant relationship between topoisomerase I gene copy number, protein expression, and cellular sensitivity to the drug SN38.
Supporting Evidence
- Topoisomerase I gene copy number varied from 1 to 6 in the studied cell lines.
- Topo I expression was highly correlated with gene copy number (r=0.92).
- Intrinsic sensitivity to SN38 was inversely related to topo I gene copy number (r=-0.904).
Takeaway
This study found that cancer cells with more copies of a specific gene are less sensitive to a drug that targets that gene, which helps explain why some tumors resist treatment.
Methodology
Fluorescence in situ hybridization was used to detect topoisomerase I gene copies in breast and colon cancer cell lines, and cytotoxicity was assessed using the MTT assay.
Limitations
The study focused on a limited number of cell lines and may not represent all tumor types.
Participant Demographics
The study included four breast cancer cell lines and one colon cancer cell line.
Statistical Information
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website